Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| bioAffinity Technologies, Inc.BIAF · Entity 8368 | Director | July 01, 2024 | July 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
bioAffinity Technologies, Inc.
Report date July 01, 2024 · Filed July 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,615 |
Reported balance
After 2024-07-01 transaction · row 1
1 source rowRow 1 · 2024-07-01 · Grant · Acquired 33,784 · Balance 66,615 F1: Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024. |
| Common StockSEC Table I · non-derivative | IndirectThe Joyce Living Trust | 583,130 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 583,130 F2: Dr. Joyce is the co-Trustee of The Joyce Living Trust (the "Trust"), together with his wife, Joyce M. Joyce, each of whom may act unilaterally with regard to voting and disposition power with respect to the shares owned by the Trust. Dr. Joyce and Mrs. Joyce are the beneficiaries of the Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.
F2: Dr. Joyce is the co-Trustee of The Joyce Living Trust (the "Trust"), together with his wife, Joyce M. Joyce, each of whom may act unilaterally with regard to voting and disposition power with respect to the shares owned by the Trust. Dr. Joyce and Mrs. Joyce are the beneficiaries of the Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2024 Filed Jul 2, 2024 22:47 UTC | bioAffinity Technologies, Inc. BIAF · Entity 8368 | GrantCommon Stock | 33,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-026090 · ownership.xml · nonDerivative · entry 1 Joyce Roby · CIK 0001993055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,615 F1 · shares: Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:45 UTC | bioAffinity Technologies, Inc. BIAF · Entity 8368 | GrantCommon Stock | 8,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-023995 · ownership.xml · nonDerivative · entry 1 Joyce Roby · CIK 0001993055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,831 F1 · shares: Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately. Read SEC document |
| January 01, 2024 Filed Jan 25, 2024 01:52 UTC | bioAffinity Technologies, Inc. BIAF · Entity 8368 | GrantCommon Stock | 12,668 | $1.48 | $18,748.64 |
DisclosureSEC source: 0001493152-24-003697 · ownership.xml · nonDerivative · entry 2 Joyce Roby · CIK 0001993055 · Director Joyce Living Trust · CIK 0001995778 · CO-TRUSTEE Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,535 F2 · shares: Represents a grant from the Issuer to Dr. Joyce of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year. Read SEC document |
| October 01, 2023 Filed Jan 25, 2024 01:52 UTC | bioAffinity Technologies, Inc. BIAF · Entity 8368 | GrantCommon Stock | 11,867 | $1.58 | $18,749.86 |
DisclosureSEC source: 0001493152-24-003697 · ownership.xml · nonDerivative · entry 1 Joyce Roby · CIK 0001993055 · Director Joyce Living Trust · CIK 0001995778 · CO-TRUSTEE Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,867 F1 · shares: Represents a grant from the Issuer to Dr. Joyce of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.